Purdue Pharma pleads guilty to criminal charges over opioid sales

US drugmaker Purdue Pharma pleaded guilty to three criminal charges over its production and sales of the prescription opioid Oxycontin, which stoked a nationwide addiction crisis, the Justice Department announced Wednesday.

Purdue also agreed to $8.3 billion in fines, damages and forfeitures to settle the against it, the department said.

In a separate agreement, the Sackler family which built Purdue to a pharmaceutical giant on the back of lucrative sales of Oxycontin, agreed to pay $225 million to resolve civil liability charges filed by the Justice Department.

Purdue pleaded guilty to one count of fraud and two counts of violating kickback laws over its marketing and sales of Oxycontin, which involved encouraging distributors and doctors to aggressively push the highly addictive drug to consumers.

"Purdue, through greed and violation of the law, prioritized money over the health and well-being of patients," said FBI assistant director Steven D'Antuono.

Explore further

OxyContin maker Purdue agrees to provide research data

© 2020 AFP

Citation: Purdue Pharma pleads guilty to criminal charges over opioid sales (2020, October 21) retrieved 6 March 2021 from https://medicalxpress.com/news/2020-10-purdue-pharma-guilty-criminal-opioid.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments